Strategic Alliance in Pharmaceutical Innovation Septerna Collaborates with Novo Nordisk on Metabolic Disease Therapie...
Significant Advances in Metabolic Disease Treatment: Septerna s Strategic Alliance with Novo Nordisk Septerna Inc. (NASDAQ: SEPN), a company committed to pioneering advancements in pharmaceutical sciences, has marked a...
May 16, 2025
• Major Pharmaceutical Preparations Industry
Partnership
Deal With Novo Nordisk Is A Game Changer U Septern
